Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-26

FDA Approved: QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for Quinapril hydrochloride/hydrochlorothiazide from Aurobindo Pharma Limited, enabling the marketing of this generi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quinapril hydrochloride/hydrochlorothiazide (Quinapril hydrochloride; hydrochlorothiazide)

Snippet

SUPPL AP for QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE (QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE)